238 related articles for article (PubMed ID: 17674979)
41. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
[TBL] [Abstract][Full Text] [Related]
42. [Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Radiation Therapy Oncology Group].
Herrmann T
Strahlenther Onkol; 1995 Apr; 171(4):244-5. PubMed ID: 7740414
[No Abstract] [Full Text] [Related]
43. [Possibilities in current radiotherapy of head and neck malignancies].
Frommhold H
Rontgenblatter; 1989 May; 42(5):216-8. PubMed ID: 2756306
[TBL] [Abstract][Full Text] [Related]
44. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
Russo G; Haddad R; Posner M; Machtay M
Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
[TBL] [Abstract][Full Text] [Related]
45. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
46. Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):512-7. PubMed ID: 19625139
[TBL] [Abstract][Full Text] [Related]
47. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
[TBL] [Abstract][Full Text] [Related]
48. Feasibility study of single agent Cisplatin and concurrent radiotherapy in Japanese patients with squamous cell carcinoma of the head and neck: preliminary results.
Zenda S; Onozawa Y; Tahara M; Kawashima M; Shikama N; Sasaki S; Boku N
Jpn J Clin Oncol; 2007 Oct; 37(10):725-9. PubMed ID: 17925299
[TBL] [Abstract][Full Text] [Related]
49. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
[TBL] [Abstract][Full Text] [Related]
51. The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy.
Jones B; Dale RG
Br J Radiol; 2005 Oct; 78(934):939-44. PubMed ID: 16177018
[TBL] [Abstract][Full Text] [Related]
52. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
53. Is high-dose intensity intraarterial cisplatin chemoradiotherapy for head and neck carcinoma feasible?
Robbins KT
Cancer; 2005 Feb; 103(3):447-50. PubMed ID: 15633205
[No Abstract] [Full Text] [Related]
54. Use of the concept of equivalent biologically effective dose (BED) to quantify the contribution of hyperthermia to local tumor control in radiohyperthermia cervical cancer trials, and comparison with radiochemotherapy results.
Plataniotis GA; Dale RG
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1538-44. PubMed ID: 19306750
[TBL] [Abstract][Full Text] [Related]
55. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
56. Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays.
Herskind C; Griebel J; Kraus-Tiefenbacher U; Wenz F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1575-81. PubMed ID: 19028280
[TBL] [Abstract][Full Text] [Related]
57. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
58. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
[TBL] [Abstract][Full Text] [Related]
59. Radiation Therapy Oncology Group (RTOG) trials for head and neck cancer.
Cox JD; Fu KK; Pajak TF; Cooper JS; Ang KK
Rays; 2000; 25(3):321-3. PubMed ID: 11367897
[TBL] [Abstract][Full Text] [Related]
60. Linear quadratic modeling of increased late normal-tissue effects in special clinical situations.
Jones B; Dale RG; Gaya AM
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):948-53. PubMed ID: 16458779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
